Page 35 - Read Online

Page 18 of 19 Ji et al. Rare Dis Orphan Drugs J 2023;2:26 https://dx.doi.org/10.20517/rdodj.2023.30

52. Kingsmore SF, Smith LD, Kunard CM, et al. A genome sequencing system for universal newborn screening, diagnosis, and precision
medicine for severe genetic diseases. Am J Hum Genet 2022;109:1605-19. DOI
53. Owen MJ, Lefebvre S, Hansen C, et al. An automated 13.5 hour system for scalable diagnosis and acute management guidance for
genetic diseases. Nat Commun 2022;13:4057. DOI PubMed PMC
54. Nurchis MC, Altamura G, Riccardi MT, et al. Whole genome sequencing diagnostic yield for paediatric patients with suspected
genetic disorders: systematic review, meta-analysis, and GRADE assessment. Arch Public Health 2023;81:93. DOI PubMed PMC
55. Sachdev R, Field M, Baynam GS, et al. Paediatric genomic testing: navigating medicare rebatable genomic testing. J Paediatr Child
Health 2021;57:477-83. DOI PubMed PMC
56. Burdick KJ, Cogan JD, Rives LC, et al; Undiagnosed Diseases Network. Limitations of exome sequencing in detecting rare and
undiagnosed diseases. Am J Med Genet A 2020;182:1400-6. DOI PubMed PMC
57. Kirk EP, Ong R, Boggs K, et al. Gene selection for the Australian reproductive genetic carrier screening project
(“Mackenzie's mission”). Eur J Hum Genet 2021;29:79-87. DOI PubMed PMC
58. Vears DF, Savulescu J, Christodoulou J, Wall M, Newson AJ. Are we ready for whole population genomic sequencing of
asymptomatic newborns? Pharmgenomics Pers Med 2023;16:681-91. DOI PubMed PMC
59. White S, Mossfield T, Fleming J, et al. Expanding the Australian newborn blood spot screening program using genomic sequencing:
do we want it and are we ready? Eur J Hum Genet 2023;31:703-11. DOI PubMed PMC
60. Johnston J, Lantos JD, Goldenberg A, Chen F, Parens E, Koenig BA; members of the NSIGHT Ethics and Policy Advisory Board.
Sequencing newborns: a call for nuanced use of genomic technologies. Hastings Center Report 2018; 48 Suppl 2:S2-6. DOI
PubMed PMC
61. Ross LF, Clayton EW. Ethical issues in newborn sequencing research: the case study of babyseq. Pediatrics 2019;144:e20191031.
DOI PubMed PMC
62. Rothstein MA. Currents in contemporary bioethics. J Law Med Ethics 2012;40:682-9. DOI PubMed
63. Botkin JR, Rothwell E. Whole genome sequencing and newborn screening. Curr Genet Med Rep 2016;4:1-6. DOI PubMed PMC
64. Woerner AC, Gallagher RC, Vockley J, Adhikari AN. The use of whole genome and exome sequencing for newborn screening:
challenges and opportunities for population health. Front Pediatr 2021;9:663752. DOI PubMed PMC
65. Newson AJ. The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing. Hum
Genet 2022;141:1035-43. DOI PubMed
66. Pichini A, Ahmed A, Patch C, et al. Developing a national newborn genomes program: an approach driven by ethics, engagement and
co-design. Front Genet 2022;13:866168. DOI PubMed PMC
67. Bhattacharjee A, Sokolsky T, Wyman SK, et al. Development of DNA confirmatory and high-risk diagnostic testing for newborns
using targeted next-generation DNA sequencing. Genet Med 2015;17:337-47. DOI
68. Easteal S, Arkell RM, Balboa RF, et al; National Centre for Indigenous Genomics. Equitable expanded carrier screening needs
indigenous clinical and population genomic data. Am J Hum Genet 2020;107:175-82. DOI
69. Ko JM, Park KS, Kang Y, et al. A new integrated newborn screening workflow can provide a shortcut to differential diagnosis and
confirmation of inherited metabolic diseases. Yonsei Med J 2018;59:652-61. DOI PubMed PMC
70. Wojcik MH, Zhang T, Ceyhan-Birsoy O, et al; BabySeq Project Team. Discordant results between conventional newborn screening
and genomic sequencing in the babyseq project. Genet Med 2021;23:1372-5. DOI
71. Downie L, Halliday J, Lewis S, Amor DJ. Principles of genomic newborn screening programs: a systematic review. JAMA Netw
Open 2021;4:e2114336. DOI PubMed PMC
72. Walker CE, Mahede T, Davis G, et al. The collective impact of rare diseases in Western Australia: an estimate using a population-
based cohort. Genetics in Medicine 2017;19:546-52. DOI PubMed PMC
73. Downie L, Halliday J, Lewis S, et al. Exome sequencing in newborns with congenital deafness as a model for genomic newborn
screening: the baby beyond hearing project. Genet Med 2020;22:937-44. DOI
74. Genetti CA, Schwartz TS, Robinson JO, et al; BabySeq Project Team. Parental interest in genomic sequencing of newborns:
enrollment experience from the babyseq project. Genet Med 2019;21:622-30. DOI PubMed PMC
75. Martin AR, Williams E, Foulger RE, et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels.
Nat Genet 2019;51:1560-5. DOI
76. Yeung A, Christodoulou J, Amor D, et al. Baby Screen+ newborn screening (version 1.108). Available from: https://panelapp.agha.
umccr.org/panels/3931/ [Last accessed on 21 Nov 2023].
77. Johnson F, Ulph F, MacLeod R, Southern KW. Receiving results of uncertain clinical relevance from population genetic screening:
systematic review & meta-synthesis of qualitative research. Eur J Hum Genet 2022;30:520-31. DOI PubMed PMC
78. Boardman F, Clark C. 'We're kind of like genetic nomads': prents' experiences of biographical disruption and uncertainty following
in/conclusive results from newborn cystic fibrosis screening. Soc Sci Med 2022;301:114972. DOI PubMed
79. Esquerda M, Palau F, Lorenzo D, et al. Ethical questions concerning newborn genetic screening. Clin Genet 2021;99:93-8. DOI
80. Financial Services Council. FSC Standard No. 11: moratorium on genetic tests in life insurance. Available from: www.fsc.org.au/
resources-category/standard/1779-standard-11-moratorium-on-genetic-tests-in-life-insurance/file [Last accessed on 21 Nov 2023].
81. Dhondt JL. Expanded newborn screening: social and ethical issues. J Inherit Metab Dis 2010;33:S211-7. DOI PubMed
82. Zacharias RL, Smith ME, King JS. The legal dimensions of genomic sequencing in newborn screening. Hastings Cent Rep 2018;48
Suppl 2:S39-41. DOI PubMed